Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
4.150
-0.110 (-2.58%)
At close: Jun 27, 2025, 4:00 PM
4.200
+0.050 (1.20%)
After-hours: Jun 27, 2025, 6:39 PM EDT

Company Description

Aurora Cannabis Inc., together with its subsidiaries, engages in production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; sale of medical and consumer use cannabis products; and the propagation of vegetables and floral plants.

Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant.

The company was founded in 2013 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc.
Aurora Cannabis logo
Country Canada
Founded 2013
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,073
CEO Miguel Martin

Contact Details

Address:
90B Street SW, Suite 2207
Edmonton, AB T6X 1V8
Canada
Phone 855 279 4652
Website auroramj.com

Stock Details

Ticker Symbol ACB
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency CAD
CIK Code 0001683541
CUSIP Number 05156X884
ISIN Number CA05156X8504
SIC Code 2833

Key Executives

Name Position
Miguel Martin Chief Executive Officer and Executive Chairman
Simona King CPA Chief Financial Officer
Alex Miller Executive Vice President of Operations and Supply Chain
Nathalie Clark Executive Vice President, General Counsel and Corporate Secretary
Andre Jerome Executive Vice President of Global Business Development
Ananth Krishnan Vice President of Capital Markets and Investor Relations
Michelle Lefler Vice President of Communications and Public Relations
Lori Schick Executive Vice President of Human Resources
Dr. Jonathan Page Ph.D. Senior Science Advisor
Rick Savone Senior Vice President of Global Government Relations

Latest SEC Filings

Date Type Title
Jun 20, 2025 6-K Report of foreign issuer
Jun 18, 2025 6-K Report of foreign issuer
Jun 18, 2025 6-K Report of foreign issuer
Jun 18, 2025 40-F Filing
Jun 4, 2025 6-K Report of foreign issuer
May 27, 2025 6-K Report of foreign issuer
Mar 20, 2025 6-K Report of foreign issuer
Feb 18, 2025 6-K Report of foreign issuer
Feb 14, 2025 SUPPL Filing
Feb 14, 2025 F-X Filing